I read a bit about it and it reads like more on-shoring supply and manufacturing capabilities as opposed to throwing money at R&D. Latter is probably more applicable to biotech. There is a point about using government power to expedite solutions for “our greatest challenges” which is encouraging for an FTO inhibitor!
I read a bit about it and it reads like more on-shoring supply...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |